Mitiglinide for type 2 diabetes treatment

Multicentre, Double-blind, Randomized Study of Mitiglinide Compared with Nateglinide in Type 2 Diabetes Mellitus Patients in China

(2013) X Gao et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Pleiotropic Effects of Mitiglinide in Type 2 Diabetes Mellitus

(2013) H Konya et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Tighter control of postprandial hyperglycemia with mitiglinide/voglibose fixed-dose combination in Japanese patients with type 2 diabetes mellitus

(2012) Masahiro Inoue   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial

(2011) L. Li et al.   DIABETES OBESITY & METABOLISM

Treatment with Glimepiride, but not Mitiglinide and Short-Acting Insulin, Resists Body Weight and Abdominal Fat Reduction Under Dietary Energy Restriction

(2011) Takanari Nakano et al.   Journal of Atherosclerosis and Thrombosis

Efficacy and safety of mitiglinide in diabetic patients on maintenance hemodialysis

(2010) Masanori Abe et al.   ENDOCRINE JOURNAL

Effect of Mitiglinide on Glycemic Control over 52 Weeks in Japanese Type 2 Diabetic Patients Insufficiently Controlled with Pioglitazone Monotherapy

(2009) Kohei KAKU et al.   ENDOCRINE JOURNAL

Addition of Mitiglinide to Pioglitazone Monotherapy Improves Overall Glycemic Control in Japanese Patients with Type 2 Diabetes: A Randomized Double Blind Trial

(2009) Kohei KAKU et al.   ENDOCRINE JOURNAL

Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis

(2009) Masanori Abe et al.   EXPERT OPINION ON PHARMACOTHERAPY

Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patients

(2008) Willy J Malaisse   EXPERT OPINION ON PHARMACOTHERAPY